Safety of the yellow fever vaccine in people living with HIV: a longitudinal study exploring post-vaccination viremia and hematological and liver kinetics

CONCLUSIONS: 17DD was safe and well-tolerated in PLWH with CD4 ≥ 200 cells/µL. Post-vaccination viremia was more frequent in PLWH than in controls. Transient and self-limited decreases in lymphocytes and neutrophils occurred early after vaccination. 17DD viremia was associated with lower lymphocytes and platelets nadir after vaccination. We did not observe elevations in ALT after 17DD vaccination.PMID:38341187 | DOI:10.1016/j.bjid.2024.103719

Source: Braz J Infect Dis - February 10, 2024 Category: Infectious Diseases Authors: Edwiges Motta Luiz Ant ônio B Camacho Ana Bispo de Filippis Marcellus Costa Luciana Pedro Sandra W Cardoso Marta Cristina de Oliveira Souza Ygara da Silva Mendes Beatriz Grinsztejn Lara E Coelho Source Type: research